Author: Randy Mellaerts & Yves MeersmanPublished: 3 September 2015
Prep: 10 minsCook: 15 minsServes: 4
This recipe offers a spicy yet cooling alternative to your standard salad dish. The sweetness of apple and the sourness of the light curry-yogurt dressing complement the chicken. This dish is also rich in vitamins and minerals that will help you to reach the recommended daily intake of nutrients.
100g lamb’s lettuce
100g rocket lettuce
2 sweet apples
150g cooked corn
350g greek yogurt (traditionally fermented)
3-4 tsp curry powder
3 tbsp olive oil
Salt and pepper
Wash the lettuce, the apple and the cucumber. Peel the cucumber and cut it with the apple into thin strips. For the curry-yogurt sauce, cut the chives.
1. Cut the chicken into small pieces and season with salt and pepper.
2. Bake the chicken in margarine or olive oil.
3. Add curry powder to the greek yogurt. Press the juice out of a lemon. Stir the juice with the yogurt. Adjust seasoning with salt and pepper.
Combine the apple, the cucumber, the cooked corn and the lettuce and give it a slight stir. Season with salt and pepper.
Lemon zest can be added to the curry-yogurt sauce for extra flavour.
The sweet apple can also be replaced by a sour apple.
This dish can be served with slices of whole grain bread or cooked rice.
Chewing and swallowing problems
The chicken can be cooked and fluffed.
Water can be added to the sauce to become the desirable consistency.
The apple can be mixed with the sauce, or an apple compote can be prepared instead of the fresh vegetables.
Nutrition value per serving size:
Energy 421 kcal / 1747 kJ
Saturated fat 8.3g
Mono-unsaturated fat 0.1g
Poly-unsaturated fat 0.2g
Of which sugars 15.2g
Scientific studies have showed that milk consumption may increase the risk of Parkinson’s disease, particularly in men. On the other hand, fermented products such as cheese or yoghurt do not show this association (Kyrozis et al., 2013). However, more studies are needed to explore the underlying mechanisms of these findings.
Do you think Parkinson’s disease has any ‘silver linings’?
A global survey asked for perspectives on life with the condition
8 months ago
35 new Parkinson’s drug trials launched in last year
Researchers launched 35 new clinical trials of Parkinson’s drug therapies in the last year, according to recent findings published in the ‘Journal of Parkinson’s Disease’. The 2023 Parkinson’s drug development pipeline report noted a slight decrease in active trials compared to the 2022 update (down from 147 to 139 overall). About one-third of trials were still in Phase 1, half were in Phase 2 – and just 20 (14%) were in Phase 3, raising concerns about ‘slow progress’. However, of the active trials logged on ClinicalTrials.gov at the time of the latest report, 35 were found to be newly registered. The report authors concluded: “The slow progress and lack of agents transitioning from Phase 2 to Phase 3 is concerning, but collective efforts by various stakeholders are being made to accelerate the clinical trial process, with the aim of bringing new therapies to the [Parkinson’s] community sooner.”
Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award
Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…
Study explores predictors of cognitive impairment in Parkinson’s disease
Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.